Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

BACKGROUND: Immune checkpoint inhibitors (ICI) are an integral part of bladder cancer therapy, however, the relevance of ICI treatment for mixed and pure squamous cell carcinoma of the bladder remains poorly studied. Therefore, we analysed the expression of programmed death-ligand 1 (PD-L1) in uroth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Morsch, Ronja, Rose, Michael, Maurer, Angela, Cassataro, Maria Angela, Braunschweig, Till, Knüchel, Ruth, Vögeli, Thomas-Alexander, Ecke, Thorsten, Eckstein, Markus, Weyerer, Veronika, Esposito, Irene, Ackermann, Maximilian, Niegisch, Günter, Gaisa, Nadine T.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079494/
https://ncbi.nlm.nih.gov/pubmed/32188412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06727-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados